NT5E and breast cancer: Jadidi-Niaragh et al. showed that CD73-siRNA encapsulated into chitosan-lactate nanoparticles suppressed CD73 expression in breast cancer cell lines and protected the oligonucleotides against serum and heparin degradation, suggesting that this system may increase siRNA performance when administered to patients by increasing the half-life of the sequences [152].